Trending Now
VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces PALISADE-1 Phase 3 Study Findings...
VistaGen Therapeutics Inc. (NASDAQ: VTGN) has revealed topline findings from the third phase PALISADE-1 study of PH94B for the treatment of acute social anxiety...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
The FDA Accepts Investigational New Drug (IND) Application for a Phase...
Capricor Therapeutics Inc. (NASDAQ:CAPR) is one of the companies fully involved in investigating exosome science. The company's exosome technology is reportedly active in several...
MAKE IT MODERN
LATEST REVIEWS
Iterum Therapeutics plc (NASDAQ:ITRM) Submits New Drug Application For Oral Sulopenem...
Iterum Therapeutics plc (NASDAQ:ITRM) has announced the submission of a New Drug Application to the US FDA for sulopenem etzadroxil/probenecid. The application is for...
MAKE IT MODERN
PERFORMANCE TRAINING
Abeona Therapeutics Inc (NASDAQ: ABEO) Reports Positive Data Of Its Ongoing Clinical Trials Of...
Abeona Therapeutics Inc (NASDAQ:ABEO) reported new interim positive data from its Phase 1/2 ongoing clinical studies of ABO-101 and ABO-102 in MPS IIIB and...
Progenity Inc. (NASDAQ: PROG) Receives Single-Molecule Detection Platform Patent From USPTO
Progenity Inc. (NASDAQ: PROG) has announced a new patent associated with a single-molecule detection platform currently under development.
The patent covers single target nucleic acid...
Mid Day Market Update – January Effect
Markets are playing a little fakeout today with some decent action in the major indexes. The IWM is down 0.5%, while the...
Dynavax Technologies Corporation (NASDAQ:DVAX) Completes Enrolment IN Study Evaluating Hepatitis B Vaccine, HEPLISAV-B
Dynavax Technologies Corporation (NASDAQ:DVAX) has announced the completion of registration of 119 patients in its clinical study evaluating its Hepatitis B vaccine HEPLISAV-B in...
Oragenics, Inc (NYSE:OGEN) Inks A Pact With Biodextris Inc To Use Three IMAs...
Oragenics, Inc (NYSE:OGEN) entered an accord with Biodextris Inc in March 2021. As per the terms of the pact, Oragenics will use three IMAs...
MAKE IT MODERN
